Next Ventures Makes Strategic Investment in BranchLab
Next Ventures, a prominent venture capital firm dedicated to fostering advancements in whole-person health, has made an exciting strategic investment in BranchLab, a leader in AI-driven solutions for healthcare marketing. This collaboration aims to shift healthcare towards a proactive and interconnected model that empowers both patients and healthcare providers with precision-driven awareness and compliant innovation.
BranchLab: Pioneering AI-Driven Healthcare Marketing
BranchLab has rapidly become an innovator in the healthcare marketing landscape, setting new benchmarks with its focus on privacy-first, outcome-based advertising. The company's flagship platform, Pathwai™, allows brands, agencies, and media partners to leverage non-health data, enabling them to design, engage, and assess audiences honed for real-world health outcomes, including prescriptions, diagnoses, and healthcare visits. This innovative approach transforms otherwise irrelevant datasets into strategic assets that are invaluable to the healthcare marketing lifecycle.
Transforming Healthcare Engagement
"BranchLab is not simply another vendor in the healthcare audience space. Their advanced AI technology enables the conversion of non-health data into actionable insights that drive tangible health outcomes," said Lance Armstrong, a Partner at Next Ventures. This partnership aims to reshape the industry by promoting equitable data ownership among entities that maintain customer relationships.
Investing in Proactive Health Solutions
This investment aligns with BranchLab's vision and Next Ventures' belief that a significant proportion of health outcomes—around 85%—are influenced by upstream factors such as wellness, nutrition, and awareness, which have historically been underfunded. By repositioning the healthcare framework from reactive approaches to proactive engagement, BranchLab aims to ensure that patients can make informed choices earlier in their health journeys.
The Vision Behind BranchLab
Josh Walsh, Co-Founder and CEO of BranchLab, shared, "From our inception, we have focused on empowering interactions that enhance public health outcomes. Our alliance with Next Ventures, which shares a mutual commitment to building a proactive and informed healthcare ecosystem, reinforces this mission. Together, we will leverage cutting-edge deep learning AI techniques to achieve measurable impacts on health."
Building a Decentralized Marketplace
BranchLab is poised to work with numerous leading brands across various sectors, including pharmaceuticals, healthcare, government, and retail. By facilitating the use of non-health data in healthcare marketing, BranchLab empowers those closest to the consumer to create specialized healthcare segments. This approach can catalyze the emergence of a more decentralized and resilient marketplace while enhancing patient outreach and reinforcing compliance and trust.
Fostering Health Sovereignty
As the healthcare sector embarks on a transformative journey towards health sovereignty, where individuals reclaim control over their well-being, Next Ventures and BranchLab are united in their goal of establishing the essential infrastructure that will bring this vision to fruition.
About BranchLab
BranchLab stands at the forefront of AI-driven technology, redefining privacy-first, outcome-based healthcare advertising. Its Pathwai™ platform is designed to help brands, agencies, and media partners optimize audience engagement for real-world outcomes like prescriptions and healthcare visits through the utilization of non-health data. BranchLab proudly operates within the United States with offices located in key markets such as New York and San Francisco.
About Next Ventures
Next Ventures is a venture capital firm that seeks to partner with founders who are reimagining the future of whole-person health. The firm champions a vision of healthcare that combines technology, data, and care in a seamless ecosystem, empowering individuals to play an active role in managing their health and longevity.
Frequently Asked Questions
What is the purpose of Next Ventures' investment in BranchLab?
The investment aims to advance AI-driven solutions that promote privacy and improve patient engagement in healthcare.
How does BranchLab leverage non-health data?
BranchLab utilizes non-health data to enhance audience targeting and engagement, optimizing healthcare marketing efforts.
What is the Pathwai™ platform?
Pathwai™ is BranchLab's platform that allows brands to design and measure audiences focused on real-world health outcomes like prescriptions and diagnoses.
How does this partnership benefit patients?
This collaboration promotes proactive healthcare solutions, enabling earlier patient engagement and informed decision-making.
What is Next Ventures' vision for the future of healthcare?
Next Ventures envisions a proactive, interconnected healthcare system that empowers individuals to take control of their well-being through technology and data.
